Halozyme Therapeutics, Inc. (HALO)

Halozyme Therapeutics Employees

Halozyme Therapeutics had 423 employees as of December 31, 2025. The number of employees increased by 73 or 20.86% compared to the previous year.

• Employees: 423
• Change (1Y): 73
• Growth (1Y): 20.86%
• Revenue / Employee: $3,301,681
• Profits / Employee: $749,147
• Market Cap: 8.24B

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	423	73	20.86%
Dec 31, 2024	350	-23	-6.17%
Dec 31, 2023	373	-20	-5.09%
Dec 31, 2022	393	248	171.03%
Dec 31, 2021	145	9	6.62%
Dec 31, 2020	136	4	3.03%
Dec 31, 2019	132	-149	-53.02%
Dec 31, 2018	281	26	10.20%
Dec 31, 2017	255	-4	-1.54%
Dec 31, 2016	259	43	19.91%
Dec 31, 2015	216	63	41.18%
Dec 31, 2014	153	-17	-10.00%
Dec 31, 2013	170	18	11.84%
Dec 31, 2012	152	17	12.59%
Dec 31, 2011	135	33	32.35%
Dec 31, 2010	102	-38	-27.14%
Dec 31, 2009	140	10	7.69%
Dec 31, 2008	130	38	41.30%
Dec 31, 2007	92	52	130.00%
Dec 31, 2006	40	-	-

Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.